跳至主要内容
临床试验/JPRN-UMIN000016007
JPRN-UMIN000016007招募中2 期

A feasibility study of adjuvant therapy with UFT/Leucovorin+Oxaliplatin following curative resection for stage III colorectal cancer - A feasibility study of adjuvant therapy with TEGAFOX following curative resection for stage III colorectal cancer

Gunma University Graduate School0 个研究点目标入组 74 人开始时间: 2014年12月19日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
74

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Multiple malignancies within five years 2. Serious complications 3. Peripheral neuropathy 4.Serious diarrhea 5. Serious drug allergy 6. Positive for HBs antigen and HCV antibody 7. Women who are pregnant, lactating, or wish to become pregnant 8. Any other cases who are regarded as inadequate for study enrollment by the investigator

研究者

发起方
Gunma University Graduate School

相似试验